Drug or technology
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 13, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2 proof-of-concept trial with completed enrollment but no results posted in this registry record; early-phase design and stated purpose to examine safety and preliminary efficacy support preliminary classification.
JUL 30, 2026 · JOURNAL ARTICLE
Journal of Affective Disorders
A rigorous per-protocol analysis of a pragmatic RCT with 416 participants and 1-year follow-up showing a clear, pre-specified outcome (quality of life endpoints) with reported effect sizes and confidence intervals, though limited by secondary analysis design and lack of primary endpoint difference.
JUL 24, 2026 · JOURNAL ARTICLE
European Journal of Psychotraumatology
A structured narrative literature review synthesizing recent clinical evidence on intensive and massed PTSD treatment programmes, providing evidence-based recommendations for clinical practice.
JUN 12, 2026 · JOURNAL ARTICLE
Dialogues in Clinical Neuroscience
A narrative review summarizing international expert consensus on PTSD treatment recommendations across psychotherapy and pharmacotherapy modalities, without new primary data or meta-analysis.
MAY 26, 2026 · JOURNAL ARTICLE
European Journal of Psychotraumatology
This is a methodological framework paper describing development of a coding system for characterizing practice elements in child trauma interventions, enabling standardized cross-study description rather than testing efficacy or effectiveness.